Ongoing education aimed at enhancing the competencies of the substance use workforce to deliver evidence-based care effectively, including accreditation.
It is an Association created to professionals in psychiatry and mental health dedicated to the Research and Treatments on Dual Disorders.
To plan and develop the required educational programs to manage the “Dual Disorder’s” concept at a worldwide level with a focus on professional education and capacitation.
The 51st KBS Symposium is hosted by Vytautas Magnus University (VMU) in collaboration with the Lithuanian University of Health Sciences, Kaunas IN, and the Kaunas City.
The 17th European Opiate Addiction Treatment Association (EUROPAD) conference will be held in Bucharest, Romania on May 29-31, 2026.
Symposia have a central theme around which the EUROPAD2026BUCHAREST scientific committee has identified topics. The structure of the symposium will take the shape of 3 presentations with 30 minutes per presentation. The length of each symposium is 90 minutes.
Join us for the 2026 Annual Meeting, May 16-20 in San Francisco for 4.5 days of engaging programming for the future of psychiatry! Early rates are now available for in-person registration.
For 15 years, the Rx and Illicit Drug Summit has been a leading force in the fight against the opioid and addiction crisis. It remains the most influential gathering of stakeholders, where groundbreaking ideas are exchanged, strategies are forged, and action takes root. Our work is not done.
From risk to resilience: Transforming youth substance use care
At NAATP, we champion addiction and mental health treatment providers by driving excellence in operations, advancing evidence-based practices, and strengthening a strong, ethical industry voice. NAATP National is where these values come to life through the leadership, innovation, and expertise of our community.
May 4-6, 2026
Amelia Island Omni Resort & Spa
Amelia Island, FL
Held in Lisbon, this face-to-face two-week course places special focus on 'A whole-of-society approach to drugs', examining how communities, professionals, policymakers and people who use substances and their families can move from awareness to effective action.